New app aims to simplify diabetes management for insulin users
NCT ID NCT07282639
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a smartphone app called DailyDose that gives personalized advice on insulin doses and carbohydrate intake for people with type 1 diabetes who use multiple daily injections. The app uses data from continuous glucose monitors and insulin pens. Researchers want to see if using the app for 24 weeks can lower blood sugar levels (HbA1c). About 99 adults will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- DailyDose smartphone app (decision support tool)
- What this could lead to
- If it works, this app could help people with type 1 diabetes better manage their blood sugar and reduce the risk of complications.
- What could go wrong
- This is a small, early-stage study (99 people) testing an app, not a new drug. The app may not work for everyone, and results may not apply to all people with diabetes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Barbara Davis Center
Aurora, Colorado, 80045, United States
-
Joslin Diabetes Center, Harvard School of Medicine
Boston, Massachusetts, 02215, United States
-
Mount Sinai School of Medicine
New York, New York, 10029, United States
-
Oregon Health & Science University , Portland
Portland, Oregon, 97239, United States
-
University of California, San Diego
La Jolla, California, 92037, United States
-
University of Southern California
Los Angeles, California, 90022, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Open-Source insulin systems match commercial ones without meal announcements?
- A glucose Monitor's second chance: can it tame type 1 diabetes in High-Risk teens?
- AI takes the wheel: could a smart algorithm optimize insulin pumps from home?
- Could a metabolic modulator help people with type 1 diabetes use insulin better?
- Immune cell study may unlock kidney protection in type 1 diabetes
- Could an arthritis drug stop type 1 diabetes before it starts?